142 related articles for article (PubMed ID: 15708693)
21. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
[TBL] [Abstract][Full Text] [Related]
22. Patent foramen ovale and migraine.
Anzola GP
Cleve Clin J Med; 2007 Feb; 74 Suppl 1():S114-7. PubMed ID: 17455558
[No Abstract] [Full Text] [Related]
23. [Patent foramen ovale and migraine].
Nau JY
Rev Med Suisse; 2006 Sep; 2(80):2205. PubMed ID: 17063657
[No Abstract] [Full Text] [Related]
24. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event].
Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A
Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604
[TBL] [Abstract][Full Text] [Related]
25. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
[TBL] [Abstract][Full Text] [Related]
26. Migraine relief after patent foramen ovale closure: should vascular risk factor control be achieved first?
Di Legge S; Sallustio F
Stroke; 2006 Dec; 37(12):2876; author reply 2877. PubMed ID: 17038653
[No Abstract] [Full Text] [Related]
27. Patent foramen ovale and cerebrovascular diseases.
Desai AJ; Fuller CJ; Jesurum JT; Reisman M
Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):446-55. PubMed ID: 16874357
[TBL] [Abstract][Full Text] [Related]
28. Patent foramen ovale and migraine headaches: the saga continues.
Tobis J
Catheter Cardiovasc Interv; 2011 Mar; 77(4):575-6. PubMed ID: 21351232
[No Abstract] [Full Text] [Related]
29. Correlation or causation: untangling the relationship between patent foramen ovale and migraine.
Adler E; Love B; Giovannone S; Volpicelli F; Goldman ME
Curr Cardiol Rep; 2007 Mar; 9(1):7-12. PubMed ID: 17362678
[TBL] [Abstract][Full Text] [Related]
30. The persistent foramen ovale and migraine.
Wilmshurst PT
Rev Neurol (Paris); 2005 Jul; 161(6-7):671-4. PubMed ID: 16141954
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.
Gupta VK
Neurology; 2004 Nov; 63(9):1760-1; author reply 1760-1. PubMed ID: 15534285
[No Abstract] [Full Text] [Related]
32. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT
Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164
[TBL] [Abstract][Full Text] [Related]
33. Early post-procedural migraine attack predicts migraine resolution after patent foramen ovale transcatheter closure.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Braggion G; Giordan M; Chinaglia M
Minerva Cardioangiol; 2008 Oct; 56(5):461-5. PubMed ID: 18813181
[TBL] [Abstract][Full Text] [Related]
34. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
Majunke N; Wallenborn J; Wunderlich N; Sievert H
Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
[TBL] [Abstract][Full Text] [Related]
35. Patent foramen ovale closure to treat migraine headache.
Orr JE; Tobis JM
Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):174-5. PubMed ID: 16568111
[No Abstract] [Full Text] [Related]
36. Marked foreign body reaction and thrombus formation after transcatheter closure of a patent foramen ovale.
Schuchlenz HW; Mannweiler S; Martin D
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):591-2. PubMed ID: 16077445
[No Abstract] [Full Text] [Related]
37. Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure.
Marie Valente A; Rhodes JF
Am Heart J; 2007 Apr; 153(4 Suppl):81-4. PubMed ID: 17394907
[No Abstract] [Full Text] [Related]
38. Efficacy of ticlopidine for preventing migraine after transcatheter closure of atrial septal defect with Amplatzer septal occluder: a case report.
Tomita H; Hatakeyama K; Soda W; Kobayashi T
J Cardiol; 2007 Jun; 49(6):357-60. PubMed ID: 17633574
[TBL] [Abstract][Full Text] [Related]
39. Rebound increase in migraines following PFO closure.
Bhindi R; Ormerod OJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):719; author reply 720. PubMed ID: 18360874
[No Abstract] [Full Text] [Related]
40. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
